THESEUS PHARMACEUTICALS INC shareholders Q3 2023

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 64 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

THESEUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 4,108,796$11,052,66117.63%
Omega Fund Management, LLC 711,479$1,913,8791.76%
Lynx1 Capital Management LP 702,415$1,889,4961.25%
Orbimed Advisors 17,713,600$47,649,5841.01%
Nextech Invest Ltd. 611,310$1,644,4240.50%
Frazier Life Sciences Management, L.P. 2,248,194$6,047,6420.40%
Affinity Asset Advisors, LLC 400,726$1,077,9530.30%
DENALI ADVISORS LLC 127,900$344,0510.12%
Rock Springs Capital Management LP 437,329$1,176,4150.03%
Forefront Analytics, LLC 17,672$47,5390.03%
Boxer Capital, LLC 150,000$403,5000.02%
UBS OCONNOR LLC 181,452$488,1060.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 232,693$625,9440.01%
GSA CAPITAL PARTNERS LLP 36,587$980.01%
PRELUDE CAPITAL MANAGEMENT, LLC 27,073$72,8260.01%
ACADIAN ASSET MANAGEMENT LLC 259,470$6960.00%
EXCHANGE TRADED CONCEPTS, LLC 36,210$97,4050.00%
Laurion Capital Management LP 171,157$460,4120.00%
MILLENNIUM MANAGEMENT LLC 1,717,862$4,621,0490.00%
Red Tortoise LLC 536$1,4420.00%

This page lists THESEUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view THESEUS PHARMACEUTICALS INC's shareholder history, click here.